VACCINES PREVENT RESPIRATORY SYNCYTIAL

Brand Owner (click to sort) Address Description
RSVAVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
RSVINFAVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
RSVIVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
RSVMATERNAVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
RSVNATALVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
RSVNATAVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
RSVPEDIAVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
RSVPREPAVAX NOVAVAX, INC. 21 Firstfield Road Gaithersburg MD 20878 Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses;Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and a method for preparing same, are also disclosed.